Scientists in the laboratory of Rendong Yang, Ph.D., associate professor of Urology, have developed a new large language model that can interpret transcriptomic data in cancer cell lines more ...

DNA's iconic double helix does more than "just" store genetic information. Under certain conditions, it can temporarily fold ...

Upregulated expression of transcription factors promoting cone identity in late-stage retinal progenitors drives development ...

The gene fusion testing market offers opportunities in developing advanced technologies like next-generation sequencing (NGS) and addressing the needs of pharmaceutical companies and hospitals for ...

When scientists sequence tumor DNA, they typically find small amounts of genetic code from bacteria, viruses and fungi – microorganisms that, if actually present in tumor tissues, could influence how ...

Total company revenue is projected at “$4.5 billion to $4.6 billion, representing reported growth of 4% to 6%,” with operating margins expected at 23.3% to 23.5% in 2026. EPS guidance is “$5.05 to ...

Illumina, Inc. ("Illumina" or the "company") today announced its financial results for the fourth quarter and fiscal year 2025. "The Illumina team delivered a strong finish to 2025, marking a return ...

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year ...

New DNA tech helps track Amazonian manatees, a shy vulnerable species, by analyzing traces of their genetic material in water ...

Two U.S. senators this week introduced a bill that would create new rules around the sale of synthetic gene sequences that ...

Detailed price information for Pacific Biosciences (PACB-Q) from The Globe and Mail including charting and trades.

Illumina, which specializes in DNA sequencing, will work on samples representing 1,300 species in the San Diego Zoo Wildlife ...